4.5 Article

MOV10 sequesters the RNP of influenza A virus in the cytoplasm and is antagonized by viral NS1 protein

期刊

BIOCHEMICAL JOURNAL
卷 476, 期 -, 页码 467-481

出版社

PORTLAND PRESS LTD
DOI: 10.1042/BCJ20180754

关键词

-

资金

  1. Ministry of Science and Technology of China [2018ZX10301408-003, 2018ZX10731101-001-018, 2012CB911103, 2013ZX10001005-001-002]
  2. National Key Plan for Scientific Research and Development of China [2016YFD0500307]
  3. National Natural Science Foundation of China [81601771, 81371808, 81528012, 81702451, 81401673]
  4. CAMS Innovation Fund for Medical Sciences [CIFMS 2018-I2M-3-004, CIFMS 2016-I2M-1-014]
  5. Canadian Institutes of Health Research [CCI-132561]

向作者/读者索取更多资源

MOV10 has emerged as an important host antiviral factor. MOV10 not only inhibits various viruses, including human immunodeficiency virus type 1, hepatitis C virus and vesicular stomatitis virus, but also restricts the activity of retroelements long interspersed nucleotide element-1, Alu, SVA and intracisternal A particles. Here, we report that MOV10 suppresses influenza A virus infection through interacting with viral nucleoprotein (NP), sequestering viral RNP in the cytoplasm and causing the degradation of viral vRNA. The antiviral activity of MOV10 depends on the integrity of P-bodies. We also found that the antiviral activity of MOV10 is partially countered by viral NS1 protein that interferes with the interaction of MOV10 with viral NP and causes MOV10 degradation through the lysosomal pathway. Moreover, NS1-defective influenza A virus is more susceptible to MOV10 restriction. Our data not only expand the antiviral spectrum of MOV10 but also reveal the NS1 protein as the first viral antagonist of MOV10.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据